89465-97-4

Basic information

• Product Name: 4-bromo-2-chloro-1-nitrobenzene
• Synonyms: 4-bromo-2-chloro-1-nitrobenzene
• CAS NO: 89465-97-4
• Molecular Formula: C₆H₃BrClNO₂
• Molecular Weight: 236.45052
• Mol File: 89465-97-4.mol

Chemical Properties

• Melting Point: 42.4 °C
• Boiling Point: 286.1±20.0 °C(Predicted)
• Appearance: /
• Density: 1.827±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-bromo-2-chloro-1-nitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-chloro-1-nitrobenzene(89465-97-4)
• EPA Substance Registry System: 4-bromo-2-chloro-1-nitrobenzene(89465-97-4)

Safety Data

• Hazardous Substances Data: 89465-97-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-bromo-2-chloro-1-nitrobenzene is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new medications due to its unique molecular structure and reactivity.
Used in Dye Industry:
In the dye industry, 4-bromo-2-chloro-1-nitrobenzene is utilized as a precursor in the production of dyes, where its specific chemical properties allow for the creation of a range of colorants for different applications.
Used in Organic Compounds Synthesis:
4-bromo-2-chloro-1-nitrobenzene is employed as an intermediate in the synthesis of other organic compounds, highlighting its versatility in organic chemistry and its importance in the preparation of specialty chemicals for various industries.
It is important to handle 4-bromo-2-chloro-1-nitrobenzene with care due to its toxic nature, ensuring that safety guidelines and regulations are strictly followed to minimize the risk of exposure and potential harm to individuals and the environment.

Upstream product

• 5228-61-5 5-bromo-2-nitroaniline 
• 825-41-2 3-chloro-4-nitroaniline 
• 108-37-2 1-bromo-3-chlorobenzene 
• 7697-37-2 nitric acid 
• 588-07-8 3-Chloroacetanilide 
• 635-22-3 4-Chloro-3-nitroaniline 
• 872266-26-7 2-bromo-4-chloro-5-nitro-aniline 
• 38762-41-3 2-chloro-4-bromoaniline 

Downstream Products

• 38762-41-3 2-chloro-4-bromoaniline 
• 863202-54-4 4-nitro-3-chlorocinnamic acid 
• 1059705-52-0 1-(3-chloro-4-nitrophenyl)-4-methylpiperazine 
• 1059705-53-1 C₁₄H₂₀ClN₃O₂ 
• 1059705-54-2 C₁₅H₁₅ClN₄O₂ 
• 861199-86-2 1-(5-bromo-2-nitrophenyl)piperidine 
• 180623-89-6 5-bromo-7-chloro-1H-indole 
• 16604-87-8 4-Brom-2-chlor-4'-hydroxy-azobenzol 

Relevant articles and documents

Discovery of 5-HT6 receptor ligands based on virtual HTS

Based on a pharmacophore alignment on a 5-HT6 ligand applying 4SCan technology, a new lead series was identified and further structurally investigated. Kis down to 8 nM were achieved.

Applicability aspects of transition metal-catalyzed aromatic amination protocols in medicinal chemistry

The application of palladium- and coppercatalyzed reactions for the aromatic amination of pharmacologically relevant scaffolds is investigated. The focus is set on the scope of several protocols for the introduction of amines of broad structural diversity, allowing for the synthesis of numerous derivatives of one biological hit structure for screening in biological assay systems. Thus, attaining optimized yields and TONs had not a major priority, most important were practical aspects, that is no further purification and drying of reagents and solvents had to be envisaged, ideally only a few transition metalbased protocols had to be applied for synthesizing structurally diverse compounds in sufficient amounts (several milligrams) for screening without any finetuning of conditions and catalytic systems.

Novel cinnamic amides

E-cinnamic amides of piperazine derivatives according to formula (I) wherein X is chloro or fluoro and R1 is an aromatic or heteroaromatic group, their pharmaceutically acceptable salts or solvates. The invention also relates to pharmaceutical

Novel bisamidate phosphonate prodrugs

Novel bisamidate phosphonate prodrugs of FBPase inhibitors of the Formula IA: and their use in the treatment of diabetes and other conditions associated with elevated blood glucose.